↓ Skip to main content

Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016…

Overview of attention for article published in Breast cancer targets and therapy, December 2018
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
42 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution
Published in
Breast cancer targets and therapy, December 2018
DOI 10.2147/bctt.s179750
Pubmed ID
Authors

Silvia Antolín, Benigno Acea, Luis Albaina, Ángel Concha, Paz Santiago, Tomás García-Caballero, Joaquín J Mosquera, José Ramón Varela, Rafaela Soler, Lourdes Calvo

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 42 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 14%
Student > Postgraduate 5 12%
Student > Master 4 10%
Student > Doctoral Student 3 7%
Researcher 3 7%
Other 7 17%
Unknown 14 33%
Readers by discipline Count As %
Medicine and Dentistry 18 43%
Nursing and Health Professions 2 5%
Computer Science 2 5%
Agricultural and Biological Sciences 1 2%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 2 5%
Unknown 16 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 December 2018.
All research outputs
#21,064,103
of 25,870,940 outputs
Outputs from Breast cancer targets and therapy
#240
of 329 outputs
Outputs of similar age
#344,014
of 448,173 outputs
Outputs of similar age from Breast cancer targets and therapy
#8
of 9 outputs
Altmetric has tracked 25,870,940 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 329 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,173 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one.